Broad use of a hormone prescribed for weight loss has spawned a flurry of menu items touted as “GLP-1 friendly,” but it’s phrase that has no strict definition.
These kitchen staples are nutrient-dense and easy to tolerate.
The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular weight-loss drugs like Ozempic and Zepbound.
As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...
Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...
A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...
Hers is currently offering 20% off GLP-1 medication for eligible subscribers who pay over $500 for weight-loss services.
The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...
The Navitus survey also found that nearly 60% of users are aware of safety concerns tied to compounded GLP-1 products. More than 86% said they would be willing to pay more for an FDA-approved ...
Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...
Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...
Hosted on MSN
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
(The Conversation) – A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results